SLC35A2 and prostate cancer: Additionally, it has been found that androgen receptor-mediated signaling inhibits UGT expression in bladder (Izumi et al., 2013; Zhang, 2013) and prostate cancer (Takayama et al., 2007), indicating a gender bias in the UGT detoxification pathway in bladder cancer.